SCHEMBL2172111

SCHEMBL2172111

Cc1ccccc1CC1CC(C(=O)O)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
AGTR2 P50052 6/20 0.39
HTRA1 Q92743 1/20 0.39
S1PR1 P21453 1/20 0.39
S1PR5 Q9H228 1/20 0.39
NR1H2 P55055 4/20 0.39
NR1H3 Q13133 4/20 0.39
TGM2 P21980 1/20 0.38
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
NAMPT P43490 1/20 0.37
UCHL1 P09936 1/20 0.37
MCL1 Q07820 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1371847 1.00 CYP1A2 (0.41) CYP1A2POLBCYP3A4CYP2C19AGTR2
SCHEMBL1372212 0.88 TSHR (0.43) AGTR2HTRA1S1PR1S1PR5NR1H2
SCHEMBL2172497 0.88 GPR119 (0.41) POLBAGTR2HTRA1NR1H2NR1H3
SCHEMBL1371902 0.88 GPR119 (0.41) POLBAGTR2HTRA1NR1H2NR1H3
SCHEMBL2185475 0.88 TSHR (0.43) AGTR2HTRA1S1PR1S1PR5NR1H2
SCHEMBL29202493 0.87 UCHL1 (0.41) AGTR2HTRA1NR1H2NR1H3UCHL1
SCHEMBL30882387 0.87 UCHL1 (0.41) AGTR2HTRA1NR1H2NR1H3UCHL1
SCHEMBL29202496 0.87 UCHL1 (0.41) AGTR2HTRA1NR1H2NR1H3UCHL1
SCHEMBL1373084 0.86 NR1H2 (0.48) AGTR2NR1H2NR1H3MCL1
SCHEMBL13687997 0.86 NR1H2 (0.48) AGTR2NR1H2NR1H3MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed